Lataa...
New criteria for response assessment: role of minimal residual disease in multiple myeloma
Assessment of minimal residual disease (MRD) is becoming standard diagnostic care for potentially curable neoplasms such as acute lymphoblastic leukemia. In multiple myeloma (MM), the majority of patients will inevitably relapse despite achievement of progressively higher complete remission (CR) rat...
Tallennettuna:
| Julkaisussa: | Blood |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Hematology
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4513329/ https://ncbi.nlm.nih.gov/pubmed/25838346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-11-568907 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|